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Background: Participation in cervical cancer screening varies by socioeconomic status. The 
aims were to assess if offering human papilloma virus (HPV) self-sampling kits has an effect on 
screening participation among various socioeconomic groups and to determine if two invitation 
strategies for offering self-sampling influence the participation rate equally.
Methods: The study was based on registry data that were applied to data from a random-
ized controlled trial (n=9,791) measuring how offering HPV self-sampling affected screening 
participation. The women received either 1) a self-sampling kit mailed directly to their homes 
(directly mailed group); 2) an invitation to order the kit (opt-in group); or 3) a standard second 
reminder to attend regular cytology screening (control group). The participation data were linked 
to registries containing socioeconomic information.
Results: Women in the directly mailed group participated significantly more than women in the 
control group, regardless of their socioeconomic status, but the largest effects were observed in 
Western immigrants (participation difference [PD]=18.1%, 95% CI=10.2%–26.0%) and social 
welfare recipients (PD=15.2%, 95% CI=9.7%–20.6%). Compared with the control group, 
opt-in self-sampling only had an insignificant effect on participation among women who were 
immigrants, retired, or less educated. Western immigrants had a significantly higher increase 
in participation than native Danish women when kits were mailed directly compared with 
the opt-in strategy (PD=18.1%, 95% CI=10.2%–26.2% and PD=5.5%, 95% CI=2.9%–8.1%, 
respectively, P=0.01).
Conclusion: All socioeconomic groups benefited from the directly mailed strategy in terms of 
higher screening participation, but Western immigrants and lower socioeconomic groups seemed 
to benefit the most. Immigrants and some lower socioeconomic groups only had insignificant 
benefits of opt-in self-sampling. The directly mailed strategy might be preferable to opt-in self-
sampling because it ensures that ethnic minority groups obtain benefits of introducing HPV 
self-sampling in an organized cervical cancer screening program.
Trial registration: Current Controlled Trials NCT02680262. Registered February 10, 2016.
Keywords: self-sampling, human papillomavirus testing, cervical cancer screening, screening 
participation, socioeconomic status, social class, mass screening
Introduction
Organized screening programs have reduced the incidence and mortality from cervi-
cal cancer in many Western countries.1–3 However, even in countries with free and 
equal access to screening for all women, social inequalities in screening participation 
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exist, with non-participation being associated with foreign 
nationality and low socioeconomic status.4–6
As most cases of cervical cancer develop in unscreened 
or under-screened women,7–9 rates of cervical cancer are 
higher among women who are of lower socioeconomic status 
than among women with a higher socioeconomic status.10,11 
Interventions aimed at reducing this inequality are warranted.
When testing for high-risk human papilloma virus 
(hrHPV) in cervical cancer screening,12,13 it is possible to 
increase screening participation by allowing women to use a 
self-sampling test kit for collection of cervicovaginal mate-
rial at home before returning the sample by mail for hrHPV 
testing (HPV self-sampling). An overall positive effect on 
participation has been shown in several trials.14 Still, the 
effect size depends on the invitation strategy, ie, it is more 
effective if the kit is mailed directly to the woman’s home than 
if it is an opt-in strategy where women must order the kit to 
get tested.14 This finding has recently been replicated among 
Danish non-participants, even if timely and convenient opt-in 
procedures were available for ordering the kit.15 However, it 
remains unclear if all socioeconomic groups may be expected 
to benefit from a self-sampling offer. Some studies report a 
positive effect of mailing self-sampling kits directly to women 
with a low socioeconomic status,16–18 whereas using this inter-
vention among immigrants has yielded conflicting results.19–21 
All extant studies have shortcomings, as they include only 
few demographic and socioeconomic factors,17–21 and rely 
on self-reported20,21 or area-based data,16–18 and no studies 
have compared the effect of mailing kits directly vs using 
an opt-in procedure.
Therefore, in this study, we use high-quality Danish 
population-based registries with individual-level data on 
socioeconomic factors that can be linked to data from a 
randomized controlled trial to measure the effect of different 
self-sampling invitation strategies on screening participation. 
The aims were to assess if HPV self-sampling has an effect 
on screening participation among all socioeconomic groups 
of non-participants, and if the two invitation strategies for 
offering self-sampling influence the participation rate equally.
Methods
setting
In Denmark, cervical cancer screening is organized as a 
nationwide integrated program based on a call–recall invita-
tional system, which keeps track of women in the screening 
population, including women entering the population, and 
those who are no longer subscribed to the program (eg, due 
to hysterectomy).22 Danish women are invited for cervical 
cancer screening every 3 years when aged 23–49 years and 
every 5 years when aged 50–64 years.23 The invitation is sent 
by letter advising the woman to book an appointment to have 
a liquid-based cervical cytology specimen collected by her 
general practitioner (GP). Non-participants receive up to 
two reminders at 3 and 6 months after the initial invitation. 
Women who do not participate despite reminders receive a 
new invitation in the next screening round if they are still 
in the screening age, unless they have actively opted out of 
the screening program. Screening, as well as follow-up and 
treatment, is provided free of charge for all citizens. The 
program follows national guidelines, but the responsibility for 
running the program according to these guidelines lies with 
the five Danish administrative regions.23 The present study 
was conducted in the Central Denmark Region, which covers 
approximately one quarter of the Danish population, with 
345,000 women in the target population for cervical cancer 
screening.24,25 The overall participation rate, defined as having 
cervical cytology within 365 days after initial invitation, is 
currently 66%, with 35% of the invited women participating 
within 90 days after receiving the invitation, 18% within 90 
days after the first reminder, and 8% within 90 days after the 
second reminder, leaving 5% to initiate their participation 
between 90 and 180 days after their second reminder.24 The 
region comprises a mix of urban and rural areas.
Design
This study was based on registry data from nationwide 
registries applied to data from a population-based random-
ized controlled effectiveness trial (Cervical HOme-based 
CancEr screening [CHOiCE]). In brief, the CHOiCE trial 
evaluated the effect on screening participation of offer-
ing self-sampling using two different invitation strategies 
compared with the standard second reminder for attending 
a regular cytology screening.15,26 The women were either 1) 
mailed a self-sampling kit directly to their home addresses 
(directly mailed group); 2) mailed an invitation to order the 
kit by e-mail, text message, phone, or via a website (opt-in 
group); or 3) mailed the standard second reminder to attend 
regular cytology screening (control group). The kit included 
a brush device27 (Evalyn® Brush, Rovers Medical Devices 
B.V, Oss, Netherlands) to collect a cervicovaginal sample, 
a leaflet, written and picture-based instructions on how to 
obtain and mail the sample, and a prestamped return envelope 
addressed to the laboratory, where the self-sample was hrHPV 
tested.26 All study material was written in Danish. Women in 
the intervention groups received identical information about 
HPV and cervical cancer and were also informed about the 
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opportunity to attend regular cytology screening. The trial 
was performed within the Danish organized cervical cancer 
screening program between March 2016 and May 2017. 
Details and results of the CHOiCE trial, including participa-
tion stratified by age groups and screening history, compli-
ance to follow-up testing among HPV-positive self-samplers 
and histological outcomes, are reported elsewhere.15,26
study population
Included in the trial were all women aged 30–64 years who 
were due to receive the second reminder from the Central 
Denmark Region between March 7, 2016, and August 8, 2016 
(n=9,791). There were no exclusion criteria.26 A flowchart for 
the study population has been published elsewhere.15
Data
socioeconomic status
Data on socioeconomic status were obtained from the popula-
tion, education, and income registries operated by Statistics 
Denmark.28–31 Socioeconomic status was measured using civil 
status, ethnicity, occupation, highest completed education, 
3-year average disposable household income, and residence 
area for the year the woman was included in the study, ie, 
2016, or by using the latest available data, ie, for household 
income, data from 2013, 2014, and 2015 were used.
Civil status was classified as married/cohabiting or living 
alone. Based on Statistics Denmark’s classification, ethnic-
ity was categorized either as native Danish, immigrants/
descendants from Western countries (EU, Andorra, Australia, 
Canada, Iceland, Lichtenstein, Monaco, New Zealand, Nor-
way, San Marino, Switzerland, and the USA), or immigrants/
descendants from non-Western countries (others).32 Occu-
pation was grouped as self-employed and chief executive, 
employed, social welfare recipient (including unemployment 
benefits, social security, and sick leave), retired (including 
disability pensioners and state pensioners), or other. Accord-
ing to the UNESCO Classification of Education, highest 
completed education was categorized into three levels: low 
level (≤10 year), medium level (11–15 years), and high level 
(>15 years).33 To account for yearly variations in income, we 
calculated the average 3-year disposable household income 
using the Organization for Economic Co-operation and 
Development (OECD)-modified scale.34 Based on increasing 
tertiles and rounded to the nearest 100 Euros, the household 
income was categorized as: low (≤26,100 Euros), middle 
(>26,100 to ≤35,700 Euros), and high (>35,700 Euros). Resi-
dence area was measured using EUROSTAT’s DEGURBA 
variable, transferred into a Danish context by Statistics 
Denmark, using the woman’s municipality code.35,36 Thus, 
residence was grouped into urban area (densely populated 
areas: at least 50% of the population lives in urban centers), 
mixed rural/urban area (intermediate density areas: less than 
50% of the population lives in rural grid cells and less than 
50% of the population lives in urban centers), or rural area 
(thinly populated area: more than 50% of the population lives 
in rural grid cells).35,36
Participation
In the CHOiCE trial, data on participation after the second 
reminder were collected from the Danish Pathology Data 
Bank (DPDB). The DPDB is a nationwide registry, which 
contains records of all pathology specimens, including 
cervical cytology samples and self-samples; it has been 
highly complete since the mid-2000s.37,38 Participation in 
the CHOiCE trial was defined as returning a self-sample or 
attending regular cytology screening at the GP within 180 
days after receiving the second reminder.15,26
Data handling
This study used individual-level record linkage of data, which 
is possible owing to the unique civil personal registration 
(CPR) number that is assigned to each Danish citizen upon 
birth and to residents upon immigration.39 The CPR number 
is registered at every contact with the health care system 
(included screening), and background data related to each 
CPR number are registered with Statistics Denmark and are 
available for research purposes.29
statistical analysis
Descriptive statistics (numbers and proportions) were used 
to compare the baseline socioeconomic characteristics of 
the women in the intervention groups and the control group. 
The participation rate in each group was calculated using 
intention-to-treat analysis. The effect of the interventions 
was measured by estimating the absolute difference in 
participation rate (PD) and participation ratio (RR), fol-
lowed by 95% confidence intervals (CIs) in the intervention 
groups compared with the control group. We also compared 
the two intervention groups to see if there was any differ-
ence in effects. Furthermore, to determine if the effect of 
the interventions was modified by socioeconomic status, 
we used generalized linear models from the binary family 
to test for interaction on the absolute scale and the ratio 
scale. P-values were derived from the Wald test.
All analyses were performed using STATA version 14 
(StataCorp LP, College Station, TX, USA).
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approval
The study was approved by the Danish Data Protection 
Agency (journal no: 1-16-02-495-15) and by the Danish 
Health Authorities (journal no: 3-3013-1407/1) and achieved 
ethical clearance at the Central Denmark Region Committees 
on Health Research Ethics (journal no.: 1-10-72-259-15).
Results
study population
Our study population included 9,791 women due to receiving 
a second reminder in the Central Denmark Region during 
the study period. These women were randomized into three 
groups. The baseline socioeconomic characteristics were 
well-balanced between the three groups (Table 1), and the 
distribution of age has previously been reported to be similar 
across the groups.15 The majority of women were character-
ized by being married/cohabiting, native Danish, employed, 
having a middle level of education, and residing in rural 
areas (Table 1). The three major Western immigrant popu-
lations originated from Poland (18.3%), Romania (14.8%), 
and Lithuania (8.2%), while the three major non-Western 
immigrant populations originated from Syria (12.6%), Turkey 
(10.5%), and Lebanon (7.9%).
Participation in relation to socioeconomic 
status
Overall, women assigned to the directly mailed group more 
often participated than those assigned to the control group, 
regardless of their civil status, ethnicity, occupation, educa-
tion, income, and residence (differences ranging from 8.0% to 
18.1%) (Table 2). Only women being self-employed and chief 
executive did not reach statistical significance (PD=10.1%, 
95% CI=–0.3%–20.5%). Compared with the control group, 
the greatest differences in participation by mailing the kit 
directly were found for Western immigrants and social 
welfare recipients (PD=18.1%, 95% CI=10.2%–26.0% and 
PD=15.2%, 95% CI=9.7%–20.6%, respectively). Regarding 
ethnicity, a stronger effect of the directly mailed intervention 
was observed among Western and non-Western immigrants 
than among native Danish women. However, these differences 
were not statistically significant (P-values for interaction: 
absolute scale=0.36 and relative scale=0.08) (Table 2).
Women assigned to opt-in self-sampling also had a 
higher participation rate than women assigned to the control 
group. This difference was independent of socioeconomic 
status, except among women who were Western immigrants 
(Table 2). However, no statistically significant effect on 
participation was seen between the opt-in and the control 
group among women who were immigrants, self-employed 
and chief executive, retired, or who had a low or high level 
of education. For the opt-in group, the largest effects were 
found for social welfare recipients and women with a middle 
level of education (PD=7.8%, 95% CI=2.6%–13.1% and 
PD=7.3%, 95% CI=4.5%–10.1%, respectively).
For all socioeconomic factors, mailing the kit directly 
to women produced a higher participation than opt-in 
self-sampling, with differences ranging from 4.2%–18.1% 
(Table 2). Still, we observed no statistically significant dif-
ferences between the directly mailed and the opt-in group 
in participation among women who were self-employed and 
chief executive, retired, or who had a low or high level of 
education. Compared with the opt-in self-sampling, mail-
ing the kit directly to Western immigrants produced a two-
Table 1 Baseline socioeconomic characteristics of the study 
population
Directly 
mailed group
(N=3,265)
Opt-in 
group
(N=3,264)
Control 
group
(N=3,262)
n (%) n (%) n (%)
Civil status
Married/cohabiting 2,256 (69.1) 2,255 (69.1) 2,281 (69.9)
living alone 974 (29.8) 969 (29.7) 955 (29.3)
Ethnicity
Danish 2,703 (82.8) 2,684 (82.2) 2,656 (81.4)
Western immigrants 210 (6.4) 231 (7.1) 241 (7.4)
non-Western immigrants 316 (9.7) 308 (9.4) 338 (10.4)
Occupation
self-employed/chief 
executive
151 (4.6) 155 (4.8) 152 (4.7)
Employed 2,100 (64.3) 2,088 (63.9) 2,071 (63.5)
social welfare recipienta 452 (13.8) 429 (13.1) 491 (15.1)
retiredb 302 (9.3) 317 (9.7) 292 (8.9)
Other 232 (7.1) 242 (7.4) 232 (7.1)
Education (years)c
≤10 561 (17.2) 577 (17.7) 588 (18.0)
11–15 2,105 (64.5) 2,058 (63.1) 2,055 (63.0)
>15 301 (9.2) 307 (9.4) 295 (9.0)
Incomed
low 1,033 (31.6) 1,005 (30.8) 1,023 (31.4)
Middle 1,024 (31.4) 1,002 (30.7) 1,040 (31.8)
high 1,012 (31.0) 1,041 (31.9) 996 (30.5)
Residence area
Urban 787 (24.1) 845 (25.9) 840 (25.8)
Mixed rural/urban 1,059 (32.4) 1,036 (31.7) 1,023 (31.4)
rural 1,384 (42.4) 1,343 (41.2) 1,373 (42.1)
Notes: number and proportion vary because of missing data. no statistically 
significant differences in the distribution of the socioeconomic characteristics 
were found between the groups (chi-square test >0.05). aincluding social security, 
unemployment benefit, and sick leave. bincluding disability pension and state pension. 
chighest obtained educational level. dOECD-adjusted disposable household income: 
see Methods section.
Abbreviation: OECD, Organization for Economic Co-operation and Development.
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times higher participation rate (16.0% vs 34.3%, RR=2.14, 
95% CI=1.51–3.04). A similar, though less pronounced, 
effect was seen among non-Western immigrants (21.8% vs 
32.6%, RR=1.50, 95% CI=1.15–1.95). The participation 
rate increased statistically significantly more among Western 
immigrants than among native  Danish women when kits 
were mailed directly compared with the opt-in self-sampling 
modality (P-values for  interaction: absolute scale=0.01 and 
relative scale<0.01) (Table 2).
Participation by cytology screening or 
self-sampling according to socioeconomic 
status
Figure 1 shows the percentage of women in each group 
who participated by regular cytology screening or by self-
sampling according to socioeconomic status. In the directly 
mailed group, self-sampling increased the participation rate, 
but it also resulted in fewer women attending regular cytol-
ogy screening. This was least pronounced for immigrants 
and social welfare recipients, where the participation rate 
in regular cytology screening was almost unaffected. In the 
opt-in group, the same trends were observed. The participa-
tion was least affected among non-Western immigrants and 
women with a middle level of education and a low income. 
For social welfare recipients, a shift toward higher regular 
cytology participation was observed. When Western immi-
grants had the choice between self-sampling and regular 
cytology screening, the majority chose self-sampling over the 
regular cytology screening (20.0% vs 14.3%). The opposite 
trend was observed for non-Western immigrants, who chose 
the regular cytology screening over self-sampling (17.7% vs 
14.9%). In the opt-in group, all socioeconomic groups chose 
the regular cytology screening over self-sampling.
Discussion
Main findings
This registry-based study revealed that, across all socio-
economic groups, mailing the self-sampling kit directly to 
women yielded a higher screening participation than a stan-
dard second reminder to attend regular cytology screening 
by the GP: the largest increase in participation was observed 
among Western immigrants and social welfare recipients. 
Inviting women to opt-in self-sampling also yielded a higher 
participation rate than the second reminder across almost 
all socioeconomic groups, but the effect was smaller than 
seen for the directly mailed group. Western immigrants had 
a significantly higher increase in participation than native 
Danish women when kits were mailed directly compared 
with the opt-in strategy.
strengths and limitations
This study included socioeconomic register-based variables 
of a high quality and validity, enabling us to give a precise 
description of the women participating in screening when 
Figure 1 Participation rate by regular cytology screening or HPV self-sampling stratified by socioeconomic status.
Notes: *Including social security, unemployment benefit, and sick leave. **Including disability pension and state pension. ***Highest obtained educational level. ****OECD-
adjusted disposable household income: see Methods section.
Abbreviations: hPV, human papilloma virus; OECD, Organization for Economic Co-operation and Development.
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hPV self-sampling in cervical cancer screening
they were given the choice between one of the two self-
sampling strategies and regular cytology screening. The 
use of data on participation from the DPDB that has highly 
valid records on all pathology specimens minimized any 
risk of information bias.37,38 The randomized controlled 
design secured an equal distribution of known and unknown 
confounders; thus, the results were unlikely to be explained 
by confounding. Furthermore, the study was embedded into 
a routine screening setting, which enhanced its validity and 
generalizability.
Nevertheless, this study has potential limitations. Miss-
ing data are a potential selection problem. The proportion of 
missing data ranged from 0.7% for the variable occupation to 
9.0% for data on education. This latter figure was primarily 
due to missing data for immigrant women.30 However, the 
distribution of missing data on education was similar for 
both participants and non-participants in the three groups, 
indicating that the estimates should be unbiased. Some of the 
stratified analyses contained a small number of women and 
have relatively wide CIs, so these results should be interpreted 
with caution. Women’s compliance with follow-up on HPV 
positive self-sample results is essential for the self-sampling 
offer to be efficient. Thus, it would have been interesting 
to stratify this outcome by the socioeconomic markers. We 
previously reported the compliance to be high for the total 
study population (90.7%).15 However, stratification was not 
possible due to limited data.
interpretation and comparison with 
previous studies
As in other countries,4,5 low participation in the Danish 
screening program is associated with having a foreign 
nationality and a low socioeconomic status.6 Still, our results 
showed that all groups of women benefited from the directly 
mailed intervention, making this invitation strategy success-
ful, independently of socioeconomic status. The greatest 
effects were seen among some hard-to-reach groups, ie, 
immigrants and social welfare recipients. This finding is in 
line with prior randomized controlled trials.16–18 However, 
the directly mailed intervention did not manage to level out 
the lower participation rates among immigrants and lower 
socioeconomic groups, as participation was lowest in these 
groups, even after the intervention.
Compared with the control group, direct mailing of the 
kits produced a slightly greater increase in participation for 
Western immigrants (18%) than for non-Western immi-
grants (13%). Although consistent with one Dutch trial,19 
this finding is in contrast to two Finnish trials that found no 
significant effect of mailing the kit directly to immigrants 
(Western or non-Western) compared with the first reminder 
for regular cytology screening.20,21 These conflicting results 
could be related to differences in the ethnic profiles of non-
participants between countries. It may be speculated if the 
lower effect among non-Western immigrants in our study 
might be explained by limited knowledge about screening 
in general,40 or if it is rooted in cultural and language bar-
riers41,42 or mistrust in one’s own ability to obtain the self-
sample correctly.41–44 However, our study was not designed 
to investigate this.
Surprisingly, we found that most non-Western immi-
grants chose to attend regular cytology screening rather 
than taking the self-sample, even when the kits were mailed 
directly to their home. An explanation for this may be simi-
lar to the one reported from English focus group studies 
showing that Muslim and Hindu women preferred attending 
cytology screening performed by a female professional 
rather than to collect a self-sample.41,42 The studies revealed 
that, while these women believed that self-sampling would 
remove some of the barriers to screening, they did not have 
trust in their own ability to take the self-sample correctly 
and worried that a HPV-positive test result could cause 
relationship problems.41,42,45 We have no way of knowing 
if this is also the case in our population of non-Western 
immigrants. The picture-based instructions showing how 
to collect self-samples should be self-explaining, but 
all written information in our study was in Danish, and 
language barriers may, therefore, be another explanation. 
Nevertheless, our data showed a good effect from offering 
non-Western immigrants the possibility of self-sampling, 
but self-sampling may not be the only answer to meet 
their needs.
Compared with the control group, opt-in self-sampling 
improved participation across almost all groups of women. 
Still, it proved overall to be less effective than direct mailing 
of kits. Opt-in self-sampling had no or only an insignificant 
effect on participation in some hard-to-reach groups, ie, 
immigrants, retired, and less educated women.
Especially, we found that mailing the kit directly doubled 
the participation rate among Western immigrants compared 
with the opt-in strategy, and a similar trend was observed 
among non-Western immigrants. Western immigrants had 
an even higher increase in participation than native Danish 
women when the kits were mailed directly compared with the 
opt-in strategy. Hence, mailing the kits directly might reduce 
the socioeconomic status gradient in screening participation. 
Even though the opt-in strategy may reduce costs and waste 
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
6.
87
.1
74
 o
n 
11
-O
ct
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2018:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1034
Tranberg et al
of unused self-sampling kits, the directly mailed strategy 
might be preferable.
A Danish study demonstrated no increased risk of cervical 
cancer in immigrants compared with the native population, 
possibly due to small numbers.11 However, Swedish and 
Dutch studies reported an increased risk among immi-
grants;46–48 especially among those from Poland,47 Central 
Africa, and Central America.46,48 These subpopulations may 
have a higher background risk of cervical cancer due to a 
high prevalence of HPV49 and poor access to cervical cancer 
screening50 in their home countries, while low compliance to 
screening in the new country may be a supplemental expla-
nation. This argument supports that engaging immigrants in 
screening by offering them the possibility of self-sampling as 
an alternative to regular cytology screening might potentially 
reduce the overall burden of the disease.
Conclusion
All socioeconomic groups benefited from the directly mailed 
strategy in terms of higher screening participation, but West-
ern immigrants and lower socioeconomic groups appeared to 
benefit the most. Immigrants and some lower socioeconomic 
groups had only insignificant benefits of opt-in self-sampling. 
The directly mailed strategy might be preferable over opt-in 
self-sampling, because it ensures that ethnic minority groups 
obtain the same or even better benefits from introducing self-
sampling in the Danish organized cervical cancer screening 
program than the rest of the population.
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